Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The rotavirus VP4 and VP7 structural proteins are the two outermost capsid components of rotavirus particles. VP4 forms spike-like projections on the virion surface and is essential for mediating the virus's initial binding to host cell receptors and subsequent penetration of the endosomal membrane, enabling genome release into the cytoplasm[1][2][6][8]. VP7 is a calcium-stabilized glycoprotein that forms a protective outer layer and is critical for virion assembly and stability; it interacts directly with VP4 to lock the spikes in place and must be removed (uncoated) for successful membrane penetration to occur during infection[1][3][5]. Both proteins are the primary targets of broadly neutralizing antibodies and constitute the immunodominant antigens included in rotavirus vaccines[4][6]. Antigenic diversity in these proteins underlies the different rotavirus serotypes and poses both an immunological and therapeutic challenge. Together, VP4 and VP7 are central to viral infectivity, tropism, and immune recognition[1][2][3][4][6][7][8].
Virus neutralization via antibody binding to VP4 or VP7, blocking cellular attachment or membrane penetration Prevention of viral entry by inhibiting conformational changes in VP4 Inhibition of uncoating or capsid assembly by interfering with VP7 stability
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Rotavirus VP4 and VP7 structural proteins (VP4, VP7).